Crohn’s Disease Monocytes Promote Intestinal Inflammation

What To Know

This report summarizes a JCI Insight study that used single-cell transcriptomic and epigenomic methods plus functional assays to compare circulating blood monocytes from newly diagnosed, treatment‑naïve Crohn’s disease patients and healthy controls.

The authors found a distinct inflammatory transcriptional and chromatin-accessibility programme in Crohn’s monocytes (including NFκB, EGR, KLF, AP-1 signatures) and evidence that interferon-γ may prime monocytes by limiting IL‑10 regulatory effects.

These altered features persisted in monocyte‑derived intestinal cells, suggesting systemic reprogramming before tissue recruitment. The study links systemic immune signalling to later macrophage behaviour in the gut and proposes circulating monocytes as contributors to intestinal inflammation in Crohn’s disease.

The work used single-cell and epigenomic approaches and functional assays; the report cites Hornsby et al., JCI Insight (2026) as the source. This is a mechanistic, translational research study rather than a clinical trial of a therapy.

It suggests potential pathways and cellular targets for future research but does not provide clinical recommendations or treatment findings.